| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | VLDLR FBLN7 RASGRP4 EFCAB6 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 LRP2 MACF1 LTBP1 LTBP2 CDH1 FBN3 | 5.80e-12 | 749 | 115 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 FRAS1 VWF CRELD2 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 LTBP1 LTBP2 FBN3 | 6.36e-11 | 188 | 115 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.41e-08 | 16 | 115 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | integrin binding | 6.97e-08 | 175 | 115 | 10 | GO:0005178 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.10e-07 | 21 | 115 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | COL3A1 VWF OBSCN ITGAE ADAM10 ITGB6 EGFL6 FBLN1 FBN1 TENM3 MACF1 ADAM2 ADAM17 CDH1 | 9.02e-06 | 599 | 115 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 DLGAP1 FRAS1 VWF OBSCN CRELD2 TUBA3E CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MACF1 LTBP1 LTBP2 FBN3 | 1.35e-05 | 891 | 115 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | reelin receptor activity | 3.29e-05 | 2 | 115 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAM30 ADAM10 F7 PREPL ST14 ADAMTS12 CORIN ADAM2 ADAM17 PLG USP1 | 3.88e-05 | 430 | 115 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.94e-05 | 12 | 115 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 6.47e-05 | 14 | 115 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | peptidase activity | PEPD ADAM30 ADAM10 F7 PREPL ST14 ADAMTS12 CORIN ADAM2 ADAM17 PLG USP1 AGTPBP1 | 1.01e-04 | 654 | 115 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.32e-04 | 85 | 115 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | dipeptidase activity | 1.43e-04 | 18 | 115 | 3 | GO:0016805 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.60e-04 | 200 | 115 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.96e-04 | 4 | 115 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.96e-04 | 4 | 115 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity involved in amyloid precursor protein catabolic process | 1.96e-04 | 4 | 115 | 2 | GO:1902945 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.98e-04 | 20 | 115 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.85e-04 | 231 | 115 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | CXCR3 chemokine receptor binding | 4.86e-04 | 6 | 115 | 2 | GO:0048248 | |
| GeneOntologyMolecularFunction | microfibril binding | 4.86e-04 | 6 | 115 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.53e-04 | 120 | 115 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 7.14e-04 | 70 | 115 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 8.18e-04 | 190 | 115 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.27e-03 | 207 | 115 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 1.44e-03 | 10 | 115 | 2 | GO:0070573 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.44e-03 | 212 | 115 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.75e-03 | 11 | 115 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.10e-03 | 156 | 115 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.86e-03 | 14 | 115 | 2 | GO:0051880 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 6.73e-07 | 4 | 115 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | COL3A1 ZEB1 ITGB6 PPM1A FBN1 FBN2 LTBP1 ADAM17 LTBP2 RNF111 DNMT1 | 2.87e-06 | 336 | 115 | 11 | GO:0071560 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.39e-06 | 276 | 115 | 10 | GO:0007179 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | COL3A1 ZEB1 ITGB6 PPM1A FBN1 FBN2 LTBP1 ADAM17 LTBP2 RNF111 DNMT1 | 3.49e-06 | 343 | 115 | 11 | GO:0071559 |
| GeneOntologyBiologicalProcess | wound healing | COL3A1 ERBB2 VWF GAS6 ARFGEF1 PF4 DTNBP1 F7 ITGB6 FBLN1 MACF1 PLG HPS5 | 3.77e-06 | 493 | 115 | 13 | GO:0042060 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COL3A1 ERBB2 ZEB1 GAS6 FUZ ITGB6 PPM1A LRP8 ADAMTS12 FBN1 FBN2 LRP2 LTBP1 ADAM17 LTBP2 RNF111 DNMT1 | 4.79e-06 | 850 | 115 | 17 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to growth factor | COL3A1 ERBB2 ZEB1 GAS6 FUZ ITGB6 PPM1A LRP8 ADAMTS12 FBN1 FBN2 LRP2 LTBP1 ADAM17 LTBP2 RNF111 DNMT1 | 7.90e-06 | 883 | 115 | 17 | GO:0070848 |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 9.26e-06 | 8 | 115 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | blood coagulation | 1.54e-05 | 260 | 115 | 9 | GO:0007596 | |
| GeneOntologyBiologicalProcess | response to wounding | COL3A1 ERBB2 VWF GAS6 ARFGEF1 PF4 DTNBP1 F7 ITGB6 FBLN1 MACF1 ADAM17 PLG HPS5 | 1.83e-05 | 659 | 115 | 14 | GO:0009611 |
| GeneOntologyBiologicalProcess | coagulation | 1.84e-05 | 266 | 115 | 9 | GO:0050817 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | COL3A1 VWF GAS6 ITGAE ITGB6 EGFL6 ADAMTS12 FBLN1 FBLN2 MACF1 PLG | 1.87e-05 | 410 | 115 | 11 | GO:0031589 |
| GeneOntologyBiologicalProcess | hemostasis | 1.95e-05 | 268 | 115 | 9 | GO:0007599 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 2.70e-05 | 11 | 115 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 3.58e-05 | 12 | 115 | 3 | GO:0032825 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | COL3A1 ZEB1 ITGB6 PPM1A FBN1 FBN2 LRP2 LTBP1 ADAM17 LTBP2 RNF111 | 3.96e-05 | 445 | 115 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.64e-05 | 13 | 115 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.64e-05 | 13 | 115 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 ERO1B GAS6 ADAM10 EGFL6 ADAMTS12 FBLN1 HMCN1 LOXL2 PLG | 5.02e-05 | 377 | 115 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 ERO1B GAS6 ADAM10 EGFL6 ADAMTS12 FBLN1 HMCN1 LOXL2 PLG | 5.13e-05 | 378 | 115 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 ERO1B GAS6 ADAM10 EGFL6 ADAMTS12 FBLN1 HMCN1 LOXL2 PLG | 5.24e-05 | 379 | 115 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | COL3A1 ZEB1 ITGB6 PPM1A FBN1 FBN2 LRP2 LTBP1 ADAM17 LTBP2 RNF111 | 8.10e-05 | 482 | 115 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL3A1 ERBB2 ZEB1 GAS6 FUZ F7 ITGB6 PPM1A ADAMTS12 FBN1 FBN2 PRKAA1 LRP2 LTBP1 ADAM17 LTBP2 EIF2AK3 RNF111 | 9.75e-05 | 1186 | 115 | 18 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.02e-04 | 192 | 115 | 7 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.05e-04 | 412 | 115 | 10 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.12e-04 | 195 | 115 | 7 | GO:1903844 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 1.25e-04 | 46 | 115 | 4 | GO:0140448 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.85e-04 | 442 | 115 | 10 | GO:0050878 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL3A1 ERBB2 OBSCN FUZ PF4 ITGB6 ST14 SBNO2 LRP8 FBN2 RNH1 LOXL2 LRP2 KDM2B MACF1 ADAM17 PLG CDH1 EIF2AK3 AGTPBP1 | 1.91e-04 | 1483 | 115 | 20 | GO:0048646 |
| GeneOntologyBiologicalProcess | protein processing | 1.99e-04 | 285 | 115 | 8 | GO:0016485 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 2.09e-04 | 21 | 115 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | tube development | COL3A1 KIF18A ERBB2 ZEB1 FUZ PF4 ITGB6 ST14 ADAMTS12 FBN1 RNH1 LOXL2 TMEM59L LRP2 KDM2B PLG CDH1 EIF2AK3 INKA1 | 2.66e-04 | 1402 | 115 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | response to vitamin K | 3.05e-04 | 5 | 115 | 2 | GO:0032571 | |
| GeneOntologyBiologicalProcess | translesion synthesis | 4.00e-04 | 26 | 115 | 3 | GO:0019985 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | COL3A1 ZEB1 FUZ BCOR ADAM10 LRP1B ST14 NLRP9 TTLL4 LRP2 KDM2B PLG CDH1 INKA1 | 5.19e-04 | 906 | 115 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 6.56e-04 | 124 | 115 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | COL3A1 ZEB1 FUZ BCOR ADAM10 LRP1B ST14 NLRP9 TTLL4 LRP2 KDM2B PLG CDH1 INKA1 | 6.64e-04 | 929 | 115 | 14 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 6.77e-04 | 31 | 115 | 3 | GO:1900048 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 6.77e-04 | 31 | 115 | 3 | GO:0030194 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7.35e-04 | 347 | 115 | 8 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 7.35e-04 | 266 | 115 | 7 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of wound healing | 7.42e-04 | 73 | 115 | 4 | GO:0090303 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 FBLN7 FRAS1 VWF PF4 PF4V1 ADAM10 F7 EGFL6 ADAMTS12 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 LTBP1 LTBP2 PLG FBN3 | 8.70e-12 | 656 | 115 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 FBLN7 FRAS1 VWF PF4 PF4V1 ADAM10 F7 EGFL6 ADAMTS12 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 LTBP1 LTBP2 PLG FBN3 | 9.24e-12 | 658 | 115 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 FRAS1 VWF PF4 PF4V1 ADAM10 F7 EGFL6 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 LTBP1 LTBP2 PLG | 8.78e-11 | 530 | 115 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 5.98e-07 | 13 | 115 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 5.85e-05 | 122 | 115 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.63e-04 | 93 | 115 | 5 | GO:0031091 | |
| GeneOntologyCellularComponent | cell surface | VLDLR IL15 SPAM1 VWF ADAM30 ITGAE ADAM10 ITGB6 ST14 LRP8 LRP2 CORIN ADAM2 ADAM17 PLG CDH1 | 3.82e-04 | 1111 | 115 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.05e-04 | 332 | 115 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 5.10e-04 | 67 | 115 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | lateral loop | 6.19e-04 | 7 | 115 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 1.31e-03 | 10 | 115 | 2 | GO:0031390 | |
| MousePheno | abnormal blood coagulation | 8.26e-06 | 240 | 100 | 10 | MP:0002551 | |
| MousePheno | abnormal hemostasis | 8.88e-06 | 242 | 100 | 10 | MP:0009676 | |
| MousePheno | Meckel's cartilage hyperplasia | 5.07e-05 | 2 | 100 | 2 | MP:0030373 | |
| MousePheno | decreased susceptibility to induced thrombosis | 5.86e-05 | 30 | 100 | 4 | MP:0031120 | |
| MousePheno | abnormal blood vessel morphology | COL3A1 VLDLR ERBB2 IL15 FRAS1 RAP1GDS1 ZEB1 PEPD FUZ CRELD2 ADAM10 PPM1A BRAP ADAMTS12 CRELD1 FBLN1 FBN1 LOXL2 LRP2 LTBP1 ADAM17 PLG HPS5 CDH1 | 8.41e-05 | 1472 | 100 | 24 | MP:0001614 |
| MousePheno | abnormal thrombosis | 1.10e-04 | 106 | 100 | 6 | MP:0005048 | |
| MousePheno | overexpanded pulmonary alveolus | 1.36e-04 | 37 | 100 | 4 | MP:0001183 | |
| MousePheno | enlarged Meckel's cartilage | 1.51e-04 | 3 | 100 | 2 | MP:0030372 | |
| Domain | EGF_Ca-bd_CS | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 5.81e-24 | 97 | 112 | 19 | IPR018097 |
| Domain | EGF_CA | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 8.84e-24 | 99 | 112 | 19 | PS01187 |
| Domain | ASX_HYDROXYL | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 1.09e-23 | 100 | 112 | 19 | PS00010 |
| Domain | EGF_CA | VLDLR FBLN7 GAS6 CRELD2 LRP1B EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 2.64e-23 | 86 | 112 | 18 | PF07645 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 3.57e-23 | 106 | 112 | 19 | IPR000152 |
| Domain | EGF_1 | VLDLR FBLN7 GAS6 CRELD2 ADAM30 LRP1B F7 ITGB6 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 ADAM2 LTBP1 LTBP2 FBN3 | 3.50e-22 | 255 | 112 | 24 | PS00022 |
| Domain | EGF_CA | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 6.06e-22 | 122 | 112 | 19 | SM00179 |
| Domain | EGF-like_CS | VLDLR FBLN7 GAS6 CRELD2 ADAM30 LRP1B F7 ITGB6 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 LTBP1 ADAM17 LTBP2 FBN3 | 6.10e-22 | 261 | 112 | 24 | IPR013032 |
| Domain | EGF-like_Ca-bd_dom | VLDLR FBLN7 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 8.38e-22 | 124 | 112 | 19 | IPR001881 |
| Domain | EGF_2 | VLDLR FBLN7 GAS6 CRELD2 ADAM30 LRP1B F7 ITGB6 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 ADAM2 LTBP1 LTBP2 FBN3 | 8.78e-22 | 265 | 112 | 24 | PS01186 |
| Domain | EGF_3 | VLDLR FBLN7 GAS6 CRELD2 ADAM30 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 ADAM2 LTBP1 LTBP2 FBN3 | 1.14e-21 | 235 | 112 | 23 | PS50026 |
| Domain | EGF-like_dom | VLDLR FBLN7 FRAS1 GAS6 CRELD2 ADAM30 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 LTBP1 LTBP2 FBN3 | 4.33e-21 | 249 | 112 | 23 | IPR000742 |
| Domain | EGF | VLDLR FBLN7 FRAS1 GAS6 CRELD2 LRP1B F7 EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 MALRD1 HMCN1 MEGF6 TENM3 LRP2 LTBP1 LTBP2 FBN3 | 2.53e-20 | 235 | 112 | 22 | SM00181 |
| Domain | Growth_fac_rcpt_ | VLDLR ERBB2 FRAS1 GAS6 CRELD2 LRP1B EGFL6 LRP8 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 7.70e-20 | 156 | 112 | 19 | IPR009030 |
| Domain | cEGF | 1.95e-16 | 26 | 112 | 10 | PF12662 | |
| Domain | cEGF | 1.95e-16 | 26 | 112 | 10 | IPR026823 | |
| Domain | EGF | VLDLR FBLN7 GAS6 LRP1B F7 LRP8 MALRD1 HMCN1 MEGF6 LRP2 LTBP1 LTBP2 FBN3 | 6.17e-13 | 126 | 112 | 13 | PF00008 |
| Domain | LDLR_class-A_CS | 8.51e-11 | 40 | 112 | 8 | IPR023415 | |
| Domain | TB | 1.47e-10 | 7 | 112 | 5 | PF00683 | |
| Domain | Ldl_recept_a | 2.33e-10 | 45 | 112 | 8 | PF00057 | |
| Domain | - | 2.80e-10 | 46 | 112 | 8 | 4.10.400.10 | |
| Domain | - | 3.91e-10 | 8 | 112 | 5 | 3.90.290.10 | |
| Domain | LDLRA_1 | 4.01e-10 | 48 | 112 | 8 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.77e-10 | 49 | 112 | 8 | IPR002172 | |
| Domain | LDLa | 4.77e-10 | 49 | 112 | 8 | SM00192 | |
| Domain | LDLRA_2 | 4.77e-10 | 49 | 112 | 8 | PS50068 | |
| Domain | TB_dom | 8.76e-10 | 9 | 112 | 5 | IPR017878 | |
| Domain | TB | 8.76e-10 | 9 | 112 | 5 | PS51364 | |
| Domain | FBN | 2.10e-07 | 3 | 112 | 3 | IPR011398 | |
| Domain | Ldl_recept_b | 1.17e-06 | 14 | 112 | 4 | PF00058 | |
| Domain | LDLRB | 1.17e-06 | 14 | 112 | 4 | PS51120 | |
| Domain | EGF_extracell | 1.56e-06 | 60 | 112 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.56e-06 | 60 | 112 | 6 | PF07974 | |
| Domain | LY | 1.59e-06 | 15 | 112 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.59e-06 | 15 | 112 | 4 | IPR000033 | |
| Domain | Pep_M12B_propep | 3.47e-06 | 39 | 112 | 5 | PF01562 | |
| Domain | Peptidase_M12B_N | 3.47e-06 | 39 | 112 | 5 | IPR002870 | |
| Domain | - | 3.47e-06 | 39 | 112 | 5 | 2.120.10.30 | |
| Domain | Furin_repeat | 3.51e-06 | 18 | 112 | 4 | IPR006212 | |
| Domain | FU | 3.51e-06 | 18 | 112 | 4 | SM00261 | |
| Domain | DISINTEGRIN_1 | 3.95e-06 | 40 | 112 | 5 | PS00427 | |
| Domain | Reprolysin | 3.95e-06 | 40 | 112 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 3.95e-06 | 40 | 112 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.95e-06 | 40 | 112 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 3.95e-06 | 40 | 112 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 4.47e-06 | 41 | 112 | 5 | IPR001762 | |
| Domain | - | 5.51e-06 | 20 | 112 | 4 | 4.10.70.10 | |
| Domain | Disintegrin | 6.78e-06 | 21 | 112 | 4 | PF00200 | |
| Domain | DISIN | 6.78e-06 | 21 | 112 | 4 | SM00050 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.99e-06 | 46 | 112 | 5 | IPR011042 | |
| Domain | hEGF | 2.25e-05 | 28 | 112 | 4 | PF12661 | |
| Domain | PF4 | 3.56e-05 | 2 | 112 | 2 | IPR027222 | |
| Domain | CYSTEINE_SWITCH | 1.05e-04 | 41 | 112 | 4 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 1.26e-04 | 43 | 112 | 4 | IPR001818 | |
| Domain | - | 1.26e-04 | 81 | 112 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 1.26e-04 | 81 | 112 | 5 | IPR024079 | |
| Domain | DCB_dom | 2.12e-04 | 4 | 112 | 2 | IPR032629 | |
| Domain | Sec7_C | 2.12e-04 | 4 | 112 | 2 | IPR015403 | |
| Domain | DUF1981 | 2.12e-04 | 4 | 112 | 2 | PF09324 | |
| Domain | Sec7_N | 2.12e-04 | 4 | 112 | 2 | IPR032691 | |
| Domain | Sec7_N | 2.12e-04 | 4 | 112 | 2 | PF12783 | |
| Domain | DCB | 2.12e-04 | 4 | 112 | 2 | PF16213 | |
| Domain | VWC | 6.17e-04 | 28 | 112 | 3 | PF00093 | |
| Domain | ANATO | 7.34e-04 | 7 | 112 | 2 | SM00104 | |
| Domain | DUF3456 | 7.34e-04 | 7 | 112 | 2 | PF11938 | |
| Domain | ANAPHYLATOXIN_2 | 7.34e-04 | 7 | 112 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 7.34e-04 | 7 | 112 | 2 | PS01177 | |
| Domain | ANATO | 7.34e-04 | 7 | 112 | 2 | PF01821 | |
| Domain | DUF3456 | 7.34e-04 | 7 | 112 | 2 | IPR021852 | |
| Domain | Anaphylatoxin/fibulin | 7.34e-04 | 7 | 112 | 2 | IPR000020 | |
| Domain | ARM-type_fold | 1.00e-03 | 339 | 112 | 8 | IPR016024 | |
| Domain | ARM-like | 1.22e-03 | 270 | 112 | 7 | IPR011989 | |
| Domain | VWFC_1 | 1.30e-03 | 36 | 112 | 3 | PS01208 | |
| Domain | VWFA | 1.50e-03 | 82 | 112 | 4 | PS50234 | |
| Domain | VWFC_2 | 1.52e-03 | 38 | 112 | 3 | PS50184 | |
| Domain | VWC | 1.52e-03 | 38 | 112 | 3 | SM00214 | |
| Domain | Laminin_EGF | 1.52e-03 | 38 | 112 | 3 | IPR002049 | |
| Domain | VWA | 1.64e-03 | 84 | 112 | 4 | SM00327 | |
| Domain | GFP-like | 1.89e-03 | 11 | 112 | 2 | IPR023413 | |
| Domain | ZF_CXXC | 1.89e-03 | 11 | 112 | 2 | PS51058 | |
| Domain | - | 1.89e-03 | 11 | 112 | 2 | 2.40.155.10 | |
| Domain | Znf_CXXC | 1.89e-03 | 11 | 112 | 2 | IPR002857 | |
| Domain | zf-CXXC | 1.89e-03 | 11 | 112 | 2 | PF02008 | |
| Domain | VWF_dom | 2.03e-03 | 42 | 112 | 3 | IPR001007 | |
| Domain | TRYPSIN_SER | 2.11e-03 | 90 | 112 | 4 | IPR033116 | |
| Domain | - | 2.22e-03 | 222 | 112 | 6 | 1.25.10.10 | |
| Domain | Coagulation_fac_subgr_Gla_dom | 2.26e-03 | 12 | 112 | 2 | IPR017857 | |
| Domain | - | 2.26e-03 | 12 | 112 | 2 | 4.10.740.10 | |
| Domain | Chemokine_CXC_CS | 2.66e-03 | 13 | 112 | 2 | IPR018048 | |
| Domain | ZINC_PROTEASE | 2.87e-03 | 98 | 112 | 4 | PS00142 | |
| Domain | VWF_A | 2.98e-03 | 99 | 112 | 4 | IPR002035 | |
| Domain | CXC_Chemokine_domain | 3.09e-03 | 14 | 112 | 2 | IPR033899 | |
| Domain | TIL_dom | 3.09e-03 | 14 | 112 | 2 | IPR002919 | |
| Domain | GLA_1 | 3.09e-03 | 14 | 112 | 2 | PS00011 | |
| Domain | GLA_2 | 3.09e-03 | 14 | 112 | 2 | PS50998 | |
| Domain | Gla | 3.09e-03 | 14 | 112 | 2 | PF00594 | |
| Domain | GLA | 3.09e-03 | 14 | 112 | 2 | SM00069 | |
| Domain | GLA_domain | 3.09e-03 | 14 | 112 | 2 | IPR000294 | |
| Domain | TRYPSIN_HIS | 3.44e-03 | 103 | 112 | 4 | IPR018114 | |
| Domain | - | 3.56e-03 | 15 | 112 | 2 | 1.10.1000.11 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.23e-12 | 44 | 89 | 9 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 VWF ITGAE ADAM10 ITGB6 FBLN1 FBLN2 FBN1 FBN2 LOXL2 LTBP1 ADAM17 LTBP2 PLG CDH1 FBN3 | 5.18e-11 | 300 | 89 | 16 | M610 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.09e-11 | 37 | 89 | 8 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.11e-09 | 39 | 89 | 7 | MM14601 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 VWF ITGAE ADAM10 ITGB6 FBLN2 FBN1 FBN2 MEGF6 LOXL2 LTBP1 LTBP2 PLG | 7.80e-09 | 258 | 89 | 13 | MM14572 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.24e-08 | 32 | 89 | 6 | MM14854 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 4.31e-07 | 25 | 89 | 5 | M39713 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.78e-06 | 140 | 89 | 8 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 8.84e-06 | 77 | 89 | 6 | MM14670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.33e-05 | 8 | 89 | 3 | M47850 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.57e-05 | 85 | 89 | 6 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.79e-05 | 94 | 89 | 6 | M1041 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 3.87e-05 | 11 | 89 | 3 | M27184 | |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 3.87e-05 | 11 | 89 | 3 | MM14897 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 9.30e-05 | 38 | 89 | 4 | MM14874 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 9.99e-05 | 118 | 89 | 6 | MM15588 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 1.03e-04 | 39 | 89 | 4 | M2844 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 1.03e-04 | 39 | 89 | 4 | MM14559 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.16e-04 | 76 | 89 | 5 | MM14867 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.15e-04 | 47 | 89 | 4 | M646 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 3.43e-04 | 22 | 89 | 3 | M39480 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 3.93e-04 | 23 | 89 | 3 | MM15936 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 5.38e-04 | 161 | 89 | 6 | M27871 | |
| Pathway | REACTOME_FERTILIZATION | 5.69e-04 | 26 | 89 | 3 | M26922 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.66e-04 | 114 | 89 | 5 | MM14571 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 8.11e-04 | 7 | 89 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M22049 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 8.11e-04 | 7 | 89 | 2 | M27199 | |
| Pathway | REACTOME_REPRODUCTION | 8.73e-04 | 30 | 89 | 3 | MM17211 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 9.65e-04 | 120 | 89 | 5 | MM14982 | |
| Pathway | BIOCARTA_CTBP1_PATHWAY | 1.08e-03 | 8 | 89 | 2 | MM1544 | |
| Pathway | BIOCARTA_CTBP1_PATHWAY | 1.08e-03 | 8 | 89 | 2 | M22019 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.12e-03 | 124 | 89 | 5 | M27285 | |
| Pathway | REACTOME_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS | 1.38e-03 | 9 | 89 | 2 | MM14614 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 1.38e-03 | 130 | 89 | 5 | MM15455 | |
| Pathway | REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS | 1.72e-03 | 10 | 89 | 2 | M26977 | |
| Pubmed | COL3A1 VWF CRELD2 ADAM10 CRELD1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 LTBP1 LTBP2 PLG | 9.01e-16 | 175 | 115 | 14 | 28071719 | |
| Pubmed | COL3A1 FRAS1 VWF PF4 PF4V1 ADAM10 FBLN1 FBLN2 FBN1 HMCN1 LTBP1 LTBP2 PLG | 1.44e-14 | 167 | 115 | 13 | 22159717 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL3A1 KIF18A LRP12 ERBB2 FRAS1 ERO1B ARFGEF2 ARFGEF1 CRELD2 ADAM10 LRP1B LRP8 CRELD1 FBLN1 UBA1 FBN1 FBN2 TENM3 LOXL2 LTBP1 ADAM17 LTBP2 EIF2AK3 VCP DNMT1 PPP6R3 | 1.76e-14 | 1201 | 115 | 26 | 35696571 |
| Pubmed | 4.51e-11 | 9 | 115 | 5 | 12122015 | ||
| Pubmed | MYT1L MAPK8IP1 VLDLR DLGAP1 RAP1GDS1 VWF DIS3L HECTD4 ZNF189 ARFGEF2 FUZ LRP1B PREPL FBN1 LRP2 MACF1 TAF6 TOP1 AGTPBP1 VCP RNF111 DNMT1 | 2.18e-10 | 1285 | 115 | 22 | 35914814 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.78e-10 | 86 | 115 | 8 | 28327460 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | COL3A1 VWF GAS6 ADAM10 FBLN1 FBLN2 FBN1 LOXL2 LTBP1 ADAM17 LTBP2 | 7.19e-10 | 248 | 115 | 11 | 24006456 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.74e-08 | 135 | 115 | 8 | 28675934 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 19332778 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 25315069 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17293099 | ||
| Pubmed | 4.64e-08 | 153 | 115 | 8 | 25037231 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 4.83e-08 | 30 | 115 | 5 | 32882513 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.41e-07 | 4 | 115 | 3 | 25034023 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 12429738 | ||
| Pubmed | VLDLR ERBB2 SPAM1 DIS3L GAS6 BCOR C2CD2L FBN2 RNH1 TMEM59L LRP2 MACF1 ADAM17 TAF6 TOP1 AGTPBP1 VCP | 1.63e-07 | 1116 | 115 | 17 | 31753913 | |
| Pubmed | 2.71e-07 | 130 | 115 | 7 | 28705898 | ||
| Pubmed | 3.35e-07 | 18 | 115 | 4 | 10827173 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.35e-07 | 18 | 115 | 4 | 39040056 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 34411563 | ||
| Pubmed | 5.97e-07 | 146 | 115 | 7 | 27068509 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 6.50e-07 | 21 | 115 | 4 | 21337463 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 19349279 | ||
| Pubmed | Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. | 6.99e-07 | 6 | 115 | 3 | 20595023 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.12e-06 | 101 | 115 | 6 | 23382219 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 12169628 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.60e-06 | 26 | 115 | 4 | 34189436 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.78e-06 | 247 | 115 | 8 | 39238192 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 GAS6 HECTD4 ZNF189 OBSCN PEPD ZNF236 F7 SBNO2 LRP8 PLEKHG4B KCNQ5 MEGF6 INTS2 LOXL2 ZNF638 MACF1 HPS5 | 1.94e-06 | 1489 | 115 | 18 | 28611215 |
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 1.95e-06 | 8 | 115 | 3 | 32948785 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | DLGAP1 VWF CRELD2 CRELD1 FBLN1 FBLN2 FBN1 MEGF6 LTBP1 VCP DNMT1 | 2.69e-06 | 560 | 115 | 11 | 21653829 |
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 38844137 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.55e-06 | 123 | 115 | 6 | 26912792 | |
| Pubmed | 3.96e-06 | 71 | 115 | 5 | 33541421 | ||
| Pubmed | 4.16e-06 | 10 | 115 | 3 | 30738849 | ||
| Pubmed | 4.76e-06 | 481 | 115 | 10 | 28190767 | ||
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 15739225 | ||
| Pubmed | PEPD BCOR PREPL FBLN1 UBA1 FBLN2 MEGF6 LRP2 LTBP1 AGTPBP1 ZNF639 | 5.87e-06 | 608 | 115 | 11 | 16713569 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 6.89e-06 | 37 | 115 | 4 | 34323105 | |
| Pubmed | Identification of transcripts with enriched expression in the developing and adult pancreas. | 7.49e-06 | 624 | 115 | 11 | 18554416 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZEB1 PEPD ARFGEF2 BCOR UBA1 ZNF638 KDM2B TAF6 TP53BP1 AGTPBP1 DNMT1 PPP6R3 | 1.03e-05 | 774 | 115 | 12 | 15302935 |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17079736 | ||
| Pubmed | Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. | 1.08e-05 | 2 | 115 | 2 | 19584296 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9886271 | ||
| Pubmed | Latent transforming growth factor-β binding proteins (LTBP-1 and LTBP-2) and gingiva keratinization. | 1.08e-05 | 2 | 115 | 2 | 25858550 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19767822 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.08e-05 | 2 | 115 | 2 | 30044367 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20959601 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16420575 | ||
| Pubmed | Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. | 1.08e-05 | 2 | 115 | 2 | 18248618 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15131124 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32538218 | ||
| Pubmed | Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo. | 1.08e-05 | 2 | 115 | 2 | 8850569 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27541285 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16912226 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.08e-05 | 2 | 115 | 2 | 20404337 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 1.08e-05 | 2 | 115 | 2 | 28669633 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.08e-05 | 2 | 115 | 2 | 8791520 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24807161 | ||
| Pubmed | CXCL4 is a novel nickel-binding protein and augments nickel allergy. | 1.08e-05 | 2 | 115 | 2 | 28319310 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 34896343 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10319581 | ||
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 1.08e-05 | 2 | 115 | 2 | 17261317 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15674322 | ||
| Pubmed | Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12. | 1.08e-05 | 2 | 115 | 2 | 38396702 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16961586 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.08e-05 | 2 | 115 | 2 | 7744963 | |
| Pubmed | Platelet factor 4 induces bone loss by inhibiting the integrin α5-FAK-ERK pathway. | 1.08e-05 | 2 | 115 | 2 | 37565509 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26408953 | ||
| Pubmed | ADAM 10 is associated with gastric cancer progression and prognosis of patients. | 1.08e-05 | 2 | 115 | 2 | 21259244 | |
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.08e-05 | 2 | 115 | 2 | 18006876 | |
| Pubmed | Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype. | 1.08e-05 | 2 | 115 | 2 | 29295527 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10716990 | ||
| Pubmed | Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules. | 1.08e-05 | 2 | 115 | 2 | 26256688 | |
| Pubmed | Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. | 1.08e-05 | 2 | 115 | 2 | 19346138 | |
| Pubmed | The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo. | 1.08e-05 | 2 | 115 | 2 | 8737292 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18200054 | ||
| Pubmed | CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection. | 1.08e-05 | 2 | 115 | 2 | 30296305 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24952873 | ||
| Pubmed | Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. | 1.08e-05 | 2 | 115 | 2 | 26518435 | |
| Pubmed | Phosphatidylserine exposure is required for ADAM17 sheddase function. | 1.08e-05 | 2 | 115 | 2 | 27161080 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18417613 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19229767 | ||
| Pubmed | Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis. | 1.08e-05 | 2 | 115 | 2 | 31343988 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12083486 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23575477 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27811364 | ||
| Pubmed | Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages. | 1.08e-05 | 2 | 115 | 2 | 25960020 | |
| Pubmed | Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. | 1.08e-05 | 2 | 115 | 2 | 1695112 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17848616 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.08e-05 | 2 | 115 | 2 | 12524050 | |
| Pubmed | CXCL4 drives fibrosis by promoting several key cellular and molecular processes. | 1.08e-05 | 2 | 115 | 2 | 34986347 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8120105 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 35419902 | ||
| Pubmed | Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice. | 1.08e-05 | 2 | 115 | 2 | 30971954 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.08e-05 | 2 | 115 | 2 | 10504303 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24055471 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26244291 | ||
| Pubmed | Pseudomonas aeruginosa Triggered Exosomal Release of ADAM10 Mediates Proteolytic Cleavage in Trans. | 1.08e-05 | 2 | 115 | 2 | 35163191 | |
| Pubmed | ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion. | 1.08e-05 | 2 | 115 | 2 | 35527514 | |
| Interaction | ZNF408 interactions | VLDLR FRAS1 FSD2 LRP1B CRELD1 FBLN2 FBN1 FBN2 LRP2 LTBP1 LTBP2 | 6.23e-10 | 145 | 114 | 11 | int:ZNF408 |
| Interaction | ZFP41 interactions | 1.07e-09 | 57 | 114 | 8 | int:ZFP41 | |
| Interaction | ST14 interactions | VLDLR ERO1B GAS6 CRELD2 ADAM30 ADAM10 ST14 FBLN1 FBN1 FBN2 TMEM59L EIF2AK3 | 2.21e-09 | 207 | 114 | 12 | int:ST14 |
| Interaction | NTN5 interactions | 3.55e-09 | 24 | 114 | 6 | int:NTN5 | |
| Interaction | IGFL3 interactions | 1.01e-08 | 75 | 114 | 8 | int:IGFL3 | |
| Interaction | FBXO2 interactions | DLGAP1 FRAS1 ERO1B GAS6 ADAM10 LRP1B ST14 BRAP FBN1 FBN2 TENM3 LOXL2 LRP2 ADAM17 VCP | 1.13e-08 | 411 | 114 | 15 | int:FBXO2 |
| Interaction | MFAP5 interactions | 4.73e-07 | 52 | 114 | 6 | int:MFAP5 | |
| Interaction | LRPAP1 interactions | 8.52e-06 | 180 | 114 | 8 | int:LRPAP1 | |
| Interaction | F7 interactions | 9.46e-06 | 24 | 114 | 4 | int:F7 | |
| Interaction | FBN1 interactions | 1.01e-05 | 51 | 114 | 5 | int:FBN1 | |
| Interaction | CHEK1 interactions | 1.07e-05 | 245 | 114 | 9 | int:CHEK1 | |
| Interaction | TIMP3 interactions | 1.21e-05 | 90 | 114 | 6 | int:TIMP3 | |
| Interaction | VCAN interactions | 1.34e-05 | 54 | 114 | 5 | int:VCAN | |
| Interaction | MAPK8IP1 interactions | 1.91e-05 | 58 | 114 | 5 | int:MAPK8IP1 | |
| Interaction | ELN interactions | 2.07e-05 | 29 | 114 | 4 | int:ELN | |
| Interaction | IL17RA interactions | 2.87e-05 | 155 | 114 | 7 | int:IL17RA | |
| Interaction | FBN2 interactions | 3.34e-05 | 65 | 114 | 5 | int:FBN2 | |
| Interaction | ANAPC10 interactions | 4.16e-05 | 68 | 114 | 5 | int:ANAPC10 | |
| Interaction | MAPK8IP2 interactions | 4.89e-05 | 115 | 114 | 6 | int:MAPK8IP2 | |
| Interaction | CEACAM8 interactions | 5.92e-05 | 119 | 114 | 6 | int:CEACAM8 | |
| Interaction | RNASE4 interactions | 6.13e-05 | 14 | 114 | 3 | int:RNASE4 | |
| Interaction | LYPD4 interactions | 7.12e-05 | 123 | 114 | 6 | int:LYPD4 | |
| Interaction | ECEL1 interactions | 1.14e-04 | 134 | 114 | 6 | int:ECEL1 | |
| Interaction | SIRPD interactions | 1.28e-04 | 86 | 114 | 5 | int:SIRPD | |
| Interaction | LDLR interactions | 1.30e-04 | 417 | 114 | 10 | int:LDLR | |
| Interaction | WNT7A interactions | 1.56e-04 | 48 | 114 | 4 | int:WNT7A | |
| Interaction | PCDHB1 interactions | 1.60e-04 | 19 | 114 | 3 | int:PCDHB1 | |
| Interaction | ODAPH interactions | 1.69e-04 | 49 | 114 | 4 | int:ODAPH | |
| Interaction | SFRP4 interactions | 1.69e-04 | 49 | 114 | 4 | int:SFRP4 | |
| Interaction | SLURP1 interactions | 1.70e-04 | 144 | 114 | 6 | int:SLURP1 | |
| Interaction | SH3GL3 interactions | 1.76e-04 | 145 | 114 | 6 | int:SH3GL3 | |
| Interaction | TAFAZZIN interactions | 1.77e-04 | 207 | 114 | 7 | int:TAFAZZIN | |
| Interaction | TIMP2 interactions | 1.80e-04 | 277 | 114 | 8 | int:TIMP2 | |
| Interaction | DEFB125 interactions | 1.87e-04 | 20 | 114 | 3 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 1.87e-04 | 20 | 114 | 3 | int:ZNF224 | |
| Interaction | ADAMTSL2 interactions | 1.89e-04 | 4 | 114 | 2 | int:ADAMTSL2 | |
| Interaction | INTS14 interactions | 2.05e-04 | 95 | 114 | 5 | int:INTS14 | |
| Interaction | USP43 interactions | 2.13e-04 | 52 | 114 | 4 | int:USP43 | |
| Interaction | EGFL6 interactions | 2.18e-04 | 21 | 114 | 3 | int:EGFL6 | |
| Interaction | PRG2 interactions | 2.19e-04 | 285 | 114 | 8 | int:PRG2 | |
| Interaction | ADAM30 interactions | 2.84e-04 | 56 | 114 | 4 | int:ADAM30 | |
| Interaction | RHBDL3 interactions | 3.14e-04 | 5 | 114 | 2 | int:RHBDL3 | |
| Interaction | LRRC7 interactions | 3.26e-04 | 58 | 114 | 4 | int:LRRC7 | |
| Interaction | TTLL4 interactions | 3.27e-04 | 24 | 114 | 3 | int:TTLL4 | |
| Interaction | FLNB interactions | 3.37e-04 | 304 | 114 | 8 | int:FLNB | |
| Interaction | MKRN2 interactions | 3.43e-04 | 385 | 114 | 9 | int:MKRN2 | |
| Interaction | PCDHGB4 interactions | 3.48e-04 | 59 | 114 | 4 | int:PCDHGB4 | |
| Cytoband | 4q12-q21 | 6.22e-06 | 2 | 115 | 2 | 4q12-q21 | |
| GeneFamily | Low density lipoprotein receptors | 1.35e-09 | 13 | 75 | 5 | 634 | |
| GeneFamily | Fibulins | 1.89e-08 | 8 | 75 | 4 | 556 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.46e-06 | 27 | 75 | 4 | 47 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.01e-04 | 4 | 75 | 2 | 628 | |
| GeneFamily | Zinc fingers CXXC-type | 1.09e-03 | 12 | 75 | 2 | 136 | |
| GeneFamily | Gla domain containing | 1.29e-03 | 13 | 75 | 2 | 1250 | |
| GeneFamily | NLR family | 4.79e-03 | 25 | 75 | 2 | 666 | |
| Coexpression | NABA_MATRISOME | COL3A1 FBLN7 IL15 FRAS1 SPAM1 VWF GAS6 CRELD2 PF4 PF4V1 ADAM30 ADAM10 F7 ST14 EGFL6 ADAMTS12 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 ADAM2 LTBP1 ADAM17 LTBP2 PLG FBN3 | 4.95e-17 | 1026 | 114 | 30 | M5889 |
| Coexpression | NABA_MATRISOME | COL3A1 FBLN7 IL15 FRAS1 SPAM1 VWF GAS6 CRELD2 PF4 PF4V1 ADAM30 ADAM10 F7 ST14 EGFL6 ADAMTS12 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 MEGF6 LOXL2 ADAM2 LTBP1 ADAM17 LTBP2 PLG | 2.79e-16 | 1008 | 114 | 29 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FRAS1 VWF GAS6 CRELD2 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 LTBP1 LTBP2 FBN3 | 1.74e-13 | 196 | 114 | 14 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 FBLN7 FRAS1 VWF GAS6 CRELD2 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 LTBP1 LTBP2 FBN3 | 1.16e-12 | 275 | 114 | 15 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN7 FRAS1 VWF GAS6 CRELD2 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 LTBP1 LTBP2 | 2.47e-12 | 191 | 114 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 FBLN7 FRAS1 VWF GAS6 CRELD2 CRELD1 FBLN1 FBLN2 FBN1 FBN2 HMCN1 LTBP1 LTBP2 | 1.35e-11 | 270 | 114 | 14 | MM17057 |
| Coexpression | NABA_ECM_REGULATORS | 9.40e-08 | 238 | 114 | 10 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.10e-07 | 242 | 114 | 10 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL15 SPAM1 PF4 PF4V1 ADAM30 ADAM10 F7 ST14 EGFL6 ADAMTS12 MEGF6 LOXL2 ADAM2 ADAM17 PLG | 7.57e-07 | 738 | 114 | 15 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL15 SPAM1 PF4 PF4V1 ADAM30 ADAM10 F7 ST14 EGFL6 ADAMTS12 MEGF6 LOXL2 ADAM2 ADAM17 PLG | 9.42e-07 | 751 | 114 | 15 | M5885 |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 2.58e-06 | 50 | 114 | 5 | MM403 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 5.51e-06 | 27 | 114 | 4 | M47994 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 5.91e-06 | 59 | 114 | 5 | M47989 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 8.52e-06 | 30 | 114 | 4 | M47990 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.60e-05 | 35 | 114 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.80e-05 | 36 | 114 | 4 | MM1212 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 2.23e-05 | 38 | 114 | 4 | M47982 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.80e-05 | 200 | 114 | 7 | M5930 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN | 2.80e-05 | 200 | 114 | 7 | M7473 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 3.07e-05 | 137 | 114 | 6 | M40313 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_DN | 5.70e-05 | 48 | 114 | 4 | M1657 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 6.70e-05 | 50 | 114 | 4 | M1259 | |
| Coexpression | ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR | 7.01e-05 | 98 | 114 | 5 | M39210 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_DN | 7.24e-05 | 51 | 114 | 4 | MM697 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | VLDLR IL15 ZEB1 VWF ZDBF2 ITGAE FBLN2 TENM3 MACF1 LTBP1 LTBP2 TP53BP1 | 7.31e-05 | 721 | 114 | 12 | M1999 |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 7.82e-05 | 52 | 114 | 4 | MM1118 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.48e-05 | 102 | 114 | 5 | MM1064 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 1.06e-04 | 107 | 114 | 5 | M4913 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.16e-04 | 174 | 114 | 6 | M45676 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | KIF18A IL15 DIS3L ARFGEF1 BCOR FANCM PPM1A LRP8 FBN1 MACF1 USP1 EIF2AK3 TOP1 | 1.37e-04 | 892 | 114 | 13 | M18120 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.66e-04 | 355 | 114 | 8 | M45758 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 1.80e-04 | 458 | 114 | 9 | M1606 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | LRP12 ERBB2 IPO4 SBNO2 C2CD2L TTLL4 LTBP1 ADAM17 LTBP2 EIF2AK3 VCP | 1.92e-04 | 681 | 114 | 11 | M5314 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.36e-04 | 69 | 114 | 4 | M10165 | |
| Coexpression | GSE27786_LSK_VS_CD8_TCELL_UP | 2.40e-04 | 199 | 114 | 6 | M4749 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.46e-04 | 128 | 114 | 5 | M6083 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN | 2.46e-04 | 200 | 114 | 6 | M6358 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | LRP12 ERBB2 IPO4 SBNO2 C2CD2L TTLL4 LTBP1 ADAM17 LTBP2 EIF2AK3 VCP | 2.52e-04 | 703 | 114 | 11 | MM1055 |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 2.67e-04 | 483 | 114 | 9 | MM1012 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.78e-04 | 72 | 114 | 4 | M9908 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 3.25e-04 | 75 | 114 | 4 | MM1084 | |
| Coexpression | PDGF_UP.V1_DN | 3.26e-04 | 136 | 114 | 5 | M2832 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 3.59e-04 | 503 | 114 | 9 | M2226 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | COL3A1 PDE3A ZDBF2 ADAMTS12 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 | 1.62e-07 | 207 | 113 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | COL3A1 VLDLR FRAS1 PDE3A ZDBF2 ADAMTS12 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 | 4.18e-07 | 354 | 113 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | COL3A1 PDE3A ZDBF2 ADAMTS12 FBLN1 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 | 1.88e-06 | 337 | 113 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 ERBB2 IL15 PDE3A ZDBF2 ZBTB1 ADAMTS12 FBLN1 FBLN2 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 INKA1 | 7.87e-06 | 827 | 113 | 16 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.59e-05 | 291 | 113 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.82e-05 | 369 | 113 | 10 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 6.25e-05 | 186 | 113 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.40e-05 | 327 | 113 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | LRP12 PDE3A EFCAB6 DIS3L ICE2 ARFGEF2 PF4 ADAM10 PREPL HMCN1 RNH1 CORIN MACF1 LTBP1 USP1 TOP1 | 6.58e-05 | 985 | 113 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | COL3A1 VLDLR FRAS1 PDE3A DOCK11 GAS6 PF4 FBLN1 FBLN2 FBN1 HMCN1 LOXL2 LRP2 LTBP2 | 6.67e-05 | 778 | 113 | 14 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | COL3A1 PDE3A ZDBF2 ADAMTS12 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 | 8.03e-05 | 418 | 113 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.75e-05 | 265 | 113 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 PDE3A HECTD4 PF4 FANCM EGFL6 TRMU FBLN2 FBN1 MEGF6 MACF1 TOP1 | 9.53e-05 | 607 | 113 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | COL3A1 GAS6 ADAMTS12 FBLN1 FBLN2 FBN1 HMCN1 TENM3 LOXL2 LTBP1 | 1.16e-04 | 437 | 113 | 10 | GSM777046_500 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.31e-04 | 281 | 113 | 8 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.31e-04 | 281 | 113 | 8 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.32e-04 | 146 | 113 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL3A1 VLDLR IL15 FRAS1 PDE3A ZDBF2 EGFL6 ADAMTS12 FBN1 FBN2 HMCN1 TENM3 LOXL2 LTBP1 | 1.34e-04 | 831 | 113 | 14 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | COL3A1 PDE3A RAP1GDS1 DIS3L ICE2 ARFGEF2 EGFL6 TRMU FBLN2 FBN1 ZNF638 MACF1 USP1 TOP1 | 1.39e-04 | 834 | 113 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.42e-04 | 148 | 113 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | COL3A1 VLDLR PDE3A HECTD4 PF4 SIAH3 FBLN1 FBN1 FBN2 HMCN1 TENM3 LTBP1 AGTPBP1 | 1.45e-04 | 734 | 113 | 13 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 1.66e-04 | 371 | 113 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL3A1 PDE3A GAS6 ADAMTS12 FBLN1 FBN1 HMCN1 TENM3 LOXL2 LTBP1 | 1.95e-04 | 466 | 113 | 10 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.56e-04 | 310 | 113 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DIS3L ICE2 ARFGEF2 CRELD2 ADAM10 PREPL BRAP CORIN MACF1 USP1 EIF2AK3 TOP1 AGTPBP1 | 2.62e-04 | 780 | 113 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.62e-04 | 311 | 113 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | VLDLR FRAS1 ST14 EGFL6 FBLN1 FBN1 FBN2 TENM3 LRP2 KDM2B CORIN LTBP1 CDH1 | 2.71e-04 | 783 | 113 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_500 | 2.76e-04 | 59 | 113 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.82e-04 | 168 | 113 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 3.00e-04 | 492 | 113 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.33e-04 | 112 | 113 | 5 | gudmap_kidney_e10.5_UretericTip_HoxB7_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.50e-04 | 246 | 113 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.56e-04 | 63 | 113 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 4.01e-04 | 65 | 113 | 4 | gudmap_kidney_e15.5_Podocyte_MafB_k4_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.38e-04 | 336 | 113 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.93e-04 | 122 | 113 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.99e-04 | 261 | 113 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | PP_MEG_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.15e-04 | 527 | 113 | 10 | PP_MEG_1000_K2 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 5.27e-04 | 189 | 113 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF18A DOCK11 ZDBF2 FANCM ZBTB1 ZNF638 USP1 TOP1 RNF111 DNMT1 | 5.54e-04 | 532 | 113 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.58e-04 | 191 | 113 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.73e-04 | 192 | 113 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL3A1 PDE3A ARFGEF2 PF4 EGFL6 TRMU FBLN2 FBN1 MEGF6 ZNF638 MACF1 TOP1 | 6.09e-04 | 744 | 113 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.28e-04 | 445 | 113 | 9 | GSM777043_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.67e-04 | 203 | 113 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 8.21e-04 | 284 | 113 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 8.40e-04 | 79 | 113 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 9.66e-04 | 82 | 113 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | COL3A1 ADAMTS12 FBLN1 FBN1 FBN2 HMCN1 TENM3 CORIN LTBP1 LTBP2 | 4.47e-11 | 181 | 115 | 10 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL3A1 FRAS1 ADAMTS12 FBLN1 FBN1 HMCN1 TENM3 MACF1 LTBP1 LTBP2 | 8.00e-11 | 192 | 115 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-10 | 200 | 115 | 10 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.47e-09 | 187 | 115 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.69e-09 | 190 | 115 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-09 | 191 | 115 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-09 | 193 | 115 | 9 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-09 | 193 | 115 | 9 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.03e-09 | 194 | 115 | 9 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.03e-09 | 194 | 115 | 9 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.22e-09 | 196 | 115 | 9 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-09 | 196 | 115 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-09 | 197 | 115 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.32e-09 | 197 | 115 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.43e-09 | 198 | 115 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.43e-09 | 198 | 115 | 9 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-09 | 198 | 115 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.65e-09 | 200 | 115 | 9 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 2.65e-09 | 200 | 115 | 9 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.65e-09 | 200 | 115 | 9 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.65e-09 | 200 | 115 | 9 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.65e-09 | 200 | 115 | 9 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-09 | 200 | 115 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-08 | 180 | 115 | 8 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-08 | 180 | 115 | 8 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.74e-08 | 184 | 115 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-08 | 185 | 115 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.85e-08 | 185 | 115 | 8 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.10e-08 | 187 | 115 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 3.37e-08 | 189 | 115 | 8 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-08 | 190 | 115 | 8 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-08 | 190 | 115 | 8 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-08 | 191 | 115 | 8 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-08 | 191 | 115 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-08 | 191 | 115 | 8 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.65e-08 | 191 | 115 | 8 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-08 | 191 | 115 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-08 | 191 | 115 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.65e-08 | 191 | 115 | 8 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-08 | 192 | 115 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-08 | 192 | 115 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.96e-08 | 193 | 115 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.12e-08 | 194 | 115 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-08 | 194 | 115 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-08 | 194 | 115 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.29e-08 | 195 | 115 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-08 | 195 | 115 | 8 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-08 | 196 | 115 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-08 | 196 | 115 | 8 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-08 | 196 | 115 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.46e-08 | 196 | 115 | 8 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-08 | 196 | 115 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-08 | 196 | 115 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-08 | 196 | 115 | 8 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.46e-08 | 196 | 115 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.46e-08 | 196 | 115 | 8 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.64e-08 | 197 | 115 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-08 | 197 | 115 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 4.64e-08 | 197 | 115 | 8 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-08 | 197 | 115 | 8 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.64e-08 | 197 | 115 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-08 | 198 | 115 | 8 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 4.83e-08 | 198 | 115 | 8 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-08 | 198 | 115 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-08 | 198 | 115 | 8 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 4.83e-08 | 198 | 115 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.83e-08 | 198 | 115 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 4.83e-08 | 198 | 115 | 8 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-08 | 198 | 115 | 8 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.02e-08 | 199 | 115 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.02e-08 | 199 | 115 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 5.02e-08 | 199 | 115 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.02e-08 | 199 | 115 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-08 | 200 | 115 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-08 | 200 | 115 | 8 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.22e-08 | 200 | 115 | 8 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.22e-08 | 200 | 115 | 8 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-08 | 200 | 115 | 8 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 5.22e-08 | 200 | 115 | 8 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-08 | 200 | 115 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-07 | 173 | 115 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-07 | 175 | 115 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-07 | 176 | 115 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-07 | 176 | 115 | 7 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-07 | 176 | 115 | 7 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-07 | 176 | 115 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.12e-07 | 178 | 115 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-07 | 178 | 115 | 7 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-07 | 178 | 115 | 7 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| Computational | ECM and collagens. | 6.05e-06 | 225 | 80 | 10 | MODULE_47 | |
| Computational | Metal / Ca ion binding. | 6.10e-06 | 133 | 80 | 8 | MODULE_324 | |
| Computational | Genes in the cancer module 349. | 2.50e-04 | 17 | 80 | 3 | MODULE_349 | |
| Drug | Rgd Peptide | 3.37e-08 | 239 | 114 | 11 | CID000104802 | |
| Drug | LMWH | COL3A1 LRP12 SPAM1 VWF ARFGEF1 PF4 PF4V1 GC F7 FBLN1 FBLN2 KCNQ5 LRP2 PLG VCP RNF111 | 2.04e-07 | 663 | 114 | 16 | CID000000772 |
| Drug | DDAVP | 2.88e-06 | 123 | 114 | 7 | CID000027991 | |
| Drug | funiferine N-oxide | 4.61e-06 | 49 | 114 | 5 | CID000191631 | |
| Drug | desmosine | 6.83e-06 | 53 | 114 | 5 | CID000025435 | |
| Drug | hyaluronan | 7.20e-06 | 263 | 114 | 9 | CID000024759 | |
| Drug | gemcitabine | 8.89e-06 | 270 | 114 | 9 | ctd:C056507 | |
| Drug | Urokinase | 1.43e-05 | 10 | 114 | 3 | DB00013 | |
| Drug | Benzophenanthridines | 2.17e-05 | 67 | 114 | 5 | ctd:D053119 | |
| Drug | 5-amidinoindole | 2.60e-05 | 12 | 114 | 3 | CID000122670 | |
| Drug | AC1NA07O | 3.37e-05 | 13 | 114 | 3 | CID004369510 | |
| Disease | connective tissue disease (implicated_via_orthology) | 5.62e-08 | 3 | 114 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Schizophrenia | MYT1L COL3A1 VLDLR DLGAP1 GC DTNBP1 SBNO2 BRAP LRP8 ADAMTS12 LRP2 KDM2B PLG DNMT1 | 8.16e-06 | 883 | 114 | 14 | C0036341 |
| Disease | dementia (is_implicated_in) | 1.20e-05 | 12 | 114 | 3 | DOID:1307 (is_implicated_in) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.74e-05 | 224 | 114 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.81e-05 | 225 | 114 | 7 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.81e-05 | 225 | 114 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | Thrombus | 3.04e-05 | 46 | 114 | 4 | C0087086 | |
| Disease | Thrombosis | 3.92e-05 | 49 | 114 | 4 | C0040053 | |
| Disease | Weill-Marchesani syndrome | 4.43e-05 | 3 | 114 | 2 | C0265313 | |
| Disease | Familial aortopathy | 4.43e-05 | 3 | 114 | 2 | cv:CN078214 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 4.43e-05 | 3 | 114 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | systemic scleroderma (implicated_via_orthology) | 4.43e-05 | 3 | 114 | 2 | DOID:418 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 4.43e-05 | 3 | 114 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 4.43e-05 | 3 | 114 | 2 | C1869114 | |
| Disease | Malignant neoplasm of breast | ERBB2 ZEB1 VWF OBSCN ARFGEF2 ADAM10 NLRP9 LOXL2 PRKAA1 MACF1 CDH1 TOP1 TP53BP1 DNMT1 | 6.98e-05 | 1074 | 114 | 14 | C0006142 |
| Disease | very low density lipoprotein cholesterol measurement | 7.02e-05 | 260 | 114 | 7 | EFO_0008317 | |
| Disease | osteonecrosis (is_marker_for) | 8.83e-05 | 4 | 114 | 2 | DOID:10159 (is_marker_for) | |
| Disease | scoliosis (is_implicated_in) | 8.83e-05 | 4 | 114 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 8.83e-05 | 4 | 114 | 2 | cv:C0265313 | |
| Disease | thoracic aortic aneurysm (biomarker_via_orthology) | 8.83e-05 | 4 | 114 | 2 | DOID:14004 (biomarker_via_orthology) | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 8.83e-05 | 4 | 114 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Flushing | 8.83e-05 | 4 | 114 | 2 | HP_0031284 | |
| Disease | optic disc size measurement | 1.49e-04 | 205 | 114 | 6 | EFO_0004832 | |
| Disease | acute myocardial infarction (biomarker_via_orthology) | 1.71e-04 | 28 | 114 | 3 | DOID:9408 (biomarker_via_orthology) | |
| Disease | diffuse plaque measurement | MYT1L ZDBF2 DTNBP1 LRP1B SIAH3 FBLN2 FBN2 KCNQ5 MACF1 FBN3 AGTPBP1 | 1.75e-04 | 758 | 114 | 11 | EFO_0010699 |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.93e-04 | 215 | 114 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | body surface area | FBLN2 FBN1 FBN2 LOXL2 MACF1 LTBP1 LTBP2 EIF2AK3 DNMT1 PPP6R3 | 2.01e-04 | 643 | 114 | 10 | EFO_0022196 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.19e-04 | 220 | 114 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.30e-04 | 222 | 114 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | Ovarian neoplasm | 3.07e-04 | 7 | 114 | 2 | cv:C0919267 | |
| Disease | Helicobacter Infections | 3.07e-04 | 7 | 114 | 2 | C0079487 | |
| Disease | Asperger syndrome | 3.07e-04 | 7 | 114 | 2 | EFO_0003757 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 3.07e-04 | 7 | 114 | 2 | DOID:3457 (is_marker_for) | |
| Disease | refractive error, self reported educational attainment | 3.08e-04 | 34 | 114 | 3 | EFO_0004784, MONDO_0004892 | |
| Disease | Drug toxicity | 3.21e-04 | 84 | 114 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 3.21e-04 | 84 | 114 | 4 | C0041755 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 3.36e-04 | 85 | 114 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | Fanconi anemia (implicated_via_orthology) | 4.08e-04 | 8 | 114 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 4.08e-04 | 8 | 114 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Disease Exacerbation | 4.62e-04 | 165 | 114 | 5 | C0235874 | |
| Disease | Myocardial Infarction | 5.13e-04 | 95 | 114 | 4 | C0027051 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.77e-04 | 264 | 114 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | triglyceride measurement, alcohol drinking | 6.00e-04 | 99 | 114 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 6.47e-04 | 101 | 114 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Acute kidney injury | 6.47e-04 | 101 | 114 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 6.47e-04 | 101 | 114 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 6.47e-04 | 101 | 114 | 4 | C0022660 | |
| Disease | Hermanski-Pudlak Syndrome | 6.52e-04 | 10 | 114 | 2 | C0079504 | |
| Disease | Brain hemorrhage | 6.52e-04 | 10 | 114 | 2 | C0553692 | |
| Disease | Hermansky-Pudlak syndrome | 6.52e-04 | 10 | 114 | 2 | cv:C0079504 | |
| Disease | Prostatic Intraepithelial Neoplasias | 7.95e-04 | 11 | 114 | 2 | C0282612 | |
| Disease | forced expiratory volume, body mass index | 7.95e-04 | 11 | 114 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | Marfan Syndrome | 7.95e-04 | 11 | 114 | 2 | C0024796 | |
| Disease | Mammary Ductal Carcinoma | 7.95e-04 | 11 | 114 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 7.95e-04 | 11 | 114 | 2 | C1134719 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 8.03e-04 | 107 | 114 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 8.53e-04 | 774 | 114 | 10 | C0023893 | |
| Disease | C-X-C motif chemokine 10 measurement | 8.60e-04 | 109 | 114 | 4 | EFO_0008056 | |
| Disease | Thromboembolism | 9.52e-04 | 12 | 114 | 2 | C0040038 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 9.52e-04 | 12 | 114 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | – | 1.12e-03 | 13 | 114 | 2 | 608446 | |
| Disease | Myocardial infarction, susceptibility to | 1.12e-03 | 13 | 114 | 2 | cv:C1832662 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.14e-03 | 53 | 114 | 3 | C4707243 | |
| Disease | diabetic retinopathy (is_marker_for) | 1.21e-03 | 54 | 114 | 3 | DOID:8947 (is_marker_for) | |
| Disease | central corneal thickness | 1.30e-03 | 309 | 114 | 6 | EFO_0005213 | |
| Disease | Metabolic Bone Disorder | 1.31e-03 | 14 | 114 | 2 | C0005944 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.31e-03 | 14 | 114 | 2 | OBA_2045142 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 1.31e-03 | 14 | 114 | 2 | EFO_0020941 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.31e-03 | 14 | 114 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | triglycerides in LDL measurement | 1.34e-03 | 56 | 114 | 3 | EFO_0022320 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.43e-03 | 315 | 114 | 6 | EFO_0004612, EFO_0008591 | |
| Disease | triglycerides in IDL measurement | 1.48e-03 | 58 | 114 | 3 | EFO_0022149 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.50e-03 | 15 | 114 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Proteinuria | 1.50e-03 | 15 | 114 | 2 | HP_0000093 | |
| Disease | Osteopenia | 1.50e-03 | 15 | 114 | 2 | C0029453 | |
| Disease | systolic blood pressure, alcohol drinking | 1.56e-03 | 128 | 114 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | Colorectal Carcinoma | 1.64e-03 | 702 | 114 | 9 | C0009402 | |
| Disease | Alpha ketoglutarate measurement | 1.71e-03 | 16 | 114 | 2 | EFO_0010457 | |
| Disease | level of Phosphatidylethanolamine (16:0_20:4) in blood serum | 1.71e-03 | 16 | 114 | 2 | OBA_2045137 | |
| Disease | triglycerides in medium LDL measurement | 1.80e-03 | 62 | 114 | 3 | EFO_0022322 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.81e-03 | 224 | 114 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | ovarian neoplasm | 1.84e-03 | 134 | 114 | 4 | C0919267 | |
| Disease | corneal resistance factor | 1.88e-03 | 451 | 114 | 7 | EFO_0010067 | |
| Disease | serum dimethylarginine measurement | 1.88e-03 | 63 | 114 | 3 | EFO_0005418 | |
| Disease | Benign neoplasm of stomach | 1.94e-03 | 17 | 114 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.94e-03 | 17 | 114 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.94e-03 | 17 | 114 | 2 | C0154060 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.99e-03 | 229 | 114 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | Malignant neoplasm of ovary | 2.00e-03 | 137 | 114 | 4 | C1140680 | |
| Disease | triglycerides in small LDL measurement | 2.06e-03 | 65 | 114 | 3 | EFO_0022323 | |
| Disease | total lipids in small VLDL | 2.25e-03 | 67 | 114 | 3 | EFO_0022148 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.40e-03 | 239 | 114 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 2.42e-03 | 19 | 114 | 2 | OBA_2045140 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.42e-03 | 19 | 114 | 2 | EFO_0004630, HP_0002140 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.58e-03 | 243 | 114 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 2.69e-03 | 20 | 114 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | coagulation factor measurement | 2.69e-03 | 20 | 114 | 2 | EFO_0004634 | |
| Disease | Prostatic Neoplasms | 2.74e-03 | 616 | 114 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.74e-03 | 616 | 114 | 8 | C0376358 | |
| Disease | stomach cancer (is_implicated_in) | 2.76e-03 | 72 | 114 | 3 | DOID:10534 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TECEAACVEAYVKEA | 101 | Q9UK28 | |
| EVTAEDGTQRCEKCS | 321 | P04626 | |
| CEGDTCQEEKIDALQ | 391 | Q7Z569 | |
| DCLDIDECASGKVIC | 171 | Q8IUX8 | |
| CIDAETLEVGDCVSV | 751 | P26358 | |
| LQDSCLTDCDVEDGT | 761 | Q9NZJ5 | |
| GLEECTCASSDGKDD | 576 | O14672 | |
| KLEAGEECDCGTEQD | 391 | Q99965 | |
| DCDDTEVASLCLEGI | 966 | Q9Y6D6 | |
| TGVLDDCLCDIDSID | 36 | Q86YB8 | |
| NCDDTEVASLCLEGI | 911 | Q9Y6D5 | |
| RAIEKGCSQDDECVS | 496 | O14490 | |
| QDVRGECIDVDECTS | 441 | Q75N90 | |
| GASGKDCTDVDECAL | 716 | Q75N90 | |
| AKGTACEDIDECSLS | 1106 | Q75N90 | |
| VRKGATGCSDVDECE | 1271 | Q75N90 | |
| DVLCADEEEDCQAAS | 1331 | Q6W2J9 | |
| KLCCTGVETEDDEDT | 591 | Q9UPW5 | |
| EIDSNATEDRCGVCL | 681 | P58397 | |
| TVEEIEACMAGCDKA | 471 | P12955 | |
| CEESLNGEDEKCRSF | 96 | A8MUP6 | |
| TLADGKSCEDVDECV | 261 | Q53RD9 | |
| VEVLEGVCSKSDFEC | 91 | Q96HD1 | |
| LKCVDIDECGTEGAN | 241 | Q96HD1 | |
| RASGALEEDSVCCVE | 51 | Q96EL1 | |
| QTGECAKVECARDEE | 316 | Q86XX4 | |
| CGDSSDEEICAKEAN | 191 | Q9Y561 | |
| ITEDGRSCKDQDECA | 146 | Q9NZR2 | |
| DDGKTCVDIDECSSG | 2961 | Q9NZR2 | |
| SLDEHGVCTADKDCE | 41 | O75648 | |
| GNVTESGCKECEELE | 126 | P40933 | |
| EITDECGISLQCKDT | 51 | Q9UQF2 | |
| CGQEDLDSTFTICED | 761 | Q8NI77 | |
| DEKGCQCDVSVEDLT | 501 | Q9NR82 | |
| FCVDEEESCKGQSSE | 1606 | Q8IYD8 | |
| EESCKGQSSEEEVCV | 1611 | Q8IYD8 | |
| LGNEESVDKTACECV | 696 | Q9UPZ3 | |
| TDCKHTEDVGVVCSD | 146 | Q9Y4K0 | |
| EGELCEEDCFSNASV | 771 | P38570 | |
| DDGTKCVDVNECETG | 851 | P98095 | |
| AEEDGDLQCLCVKTT | 36 | P10720 | |
| ECGEDMLSTDSCKEA | 491 | P18564 | |
| GDHCEDINECLEDKS | 1156 | Q14766 | |
| SADGRTCEDIDECVN | 1236 | Q14766 | |
| GCDLEQCKEAAAAEE | 86 | Q14432 | |
| AKDCASAGELVDSEV | 66 | Q96EV8 | |
| TKNEACEDGVSDLVC | 286 | Q9H0H0 | |
| LSEGGCSEDELLEKC | 51 | Q8TDF6 | |
| TCELSVEKVCDEDGE | 706 | O94854 | |
| RCDGTKDCSDDADEI | 46 | P98164 | |
| KDCSDDADEIGCAVV | 51 | P98164 | |
| DKDCVDGSDEVGCVL | 1171 | P98164 | |
| KTCEDIDECDILGSC | 1386 | P98164 | |
| KCDGSADCLDASDEA | 3816 | P98164 | |
| EEDVCGCLEAGIRTE | 446 | Q86UT6 | |
| DEKDESLCLSSSCEG | 86 | Q96FC9 | |
| TKGGCCEVITEEAAA | 1576 | Q9Y4D8 | |
| ENGTCIDIDECKDGT | 5266 | Q96RW7 | |
| EVLEGESCSFECVLS | 2746 | Q5VST9 | |
| EDNSCKDIDECESGI | 256 | P23142 | |
| LSDVDGVTCEDIDEC | 471 | P23142 | |
| DDSKDDCSLFEVECI | 236 | Q4G163 | |
| LVDDCGDRTDEVNCA | 846 | Q5VYJ5 | |
| IVEDNEECDCGSTEE | 406 | Q9UKF2 | |
| SDTDEECLIIDTECK | 571 | Q659A1 | |
| VCLVCGEAGKEDTVE | 661 | Q8NHM5 | |
| IDEDCEKDEDSSSLC | 146 | Q5JSL3 | |
| ELEGTEELCCVAELD | 301 | O14523 | |
| EVLEECGCSLTEGEL | 991 | Q5THR3 | |
| SRIKGTQCEDIDECE | 901 | P35555 | |
| VPSADGKACEDIDEC | 1436 | P35555 | |
| LQEDGRSCKDLDECA | 2476 | P35555 | |
| LCENDCDDKASGESP | 311 | Q8TF46 | |
| DGRTCQDIDECADSE | 191 | Q14393 | |
| DEKDESLCLSSSCEG | 86 | A8MPP1 | |
| VDKTEDSLEGCLDCL | 16 | P52306 | |
| VCDGDHDCVDKSDEV | 361 | Q9Y5Q5 | |
| EVTSDEKGCQDVDEC | 1041 | Q14767 | |
| EKGCQDVDECASRAS | 1046 | Q14767 | |
| CFCEDLERNDGSTEK | 681 | Q8NCS7 | |
| DSGSVLCDDIICDDQ | 56 | P02461 | |
| DTDAVDVCIADGVCI | 451 | P38567 | |
| KQDANGDCIDVDECT | 526 | P35556 | |
| GQCADVDECSLAEKT | 286 | Q6UXH1 | |
| DEKEDTCAAVGEISV | 671 | Q8TEX9 | |
| DQVTTLEVSVCDCEG | 676 | P12830 | |
| DSELIGDLTQCVDCV | 141 | Q9BT04 | |
| SDEDDCPKKTCADSD | 76 | Q14114 | |
| LAADGKACEDVDECA | 276 | O75095 | |
| EITEACVGSCEAKRA | 226 | P49848 | |
| GSLERECKEEQCSFE | 71 | P08709 | |
| DEEEAADVFCVTCKT | 171 | A1L4K1 | |
| VLECVDSVITDGDCL | 221 | Q8IW03 | |
| ESRNGCLDVEKDCSI | 951 | Q9Y2G9 | |
| DCFEVTLKCEEGEDE | 11 | Q9BUA3 | |
| LGAGSIEECAAKCEE | 41 | P00747 | |
| ESCDEVILLEDGEIC | 666 | Q96J65 | |
| EVCEKFECSEEEVLS | 306 | Q13131 | |
| KVCGNSRVDEGEECD | 476 | P78536 | |
| AEDDTVCLDLGKCKD | 561 | P78536 | |
| LGKCDISSEVCEDIA | 721 | Q7RTR0 | |
| AEVKTQETHECDACG | 591 | O75820 | |
| VTCKECEDLGVEGTD | 1576 | Q96KV7 | |
| TEKSADIVICDEECD | 101 | Q9UID6 | |
| EGCDVCTCTDMEDAV | 2446 | P04275 | |
| EEGTEEDTEEKCTIC | 931 | Q6ZNA4 | |
| EAVCIVLSDDTCSDE | 66 | P55072 | |
| TDDLEKVCNEVVDTC | 261 | P35813 | |
| GCTKEEDVLASSACV | 131 | Q96PX9 | |
| ECDGKEDCSDGSDEK | 586 | Q9Y5Y6 | |
| ECTDLDSRCEIISDG | 76 | Q96SK3 | |
| EVVSLTEACCAEGAD | 66 | P02774 | |
| ECIDIEDKSCDFFGS | 1566 | Q9HCK1 | |
| DDCGLTEARCKDISS | 36 | P13489 | |
| CTDSKDNEGDGLIDC | 781 | Q9P273 | |
| GCCLVRSKDEEADND | 126 | Q4J6C6 | |
| VAEDVCIDLTCDSGS | 611 | Q12888 | |
| LELCCNDESGEDVEV | 1036 | P22314 | |
| AEAEEDGDLQCLCVK | 31 | P02776 | |
| EEVSCLCFTDGKTVA | 196 | P22102 | |
| DEAGCTVKDDECESD | 101 | P37275 | |
| EDAENASCELCGLTI | 416 | Q9Y2K1 | |
| EKEENLICSECGDEF | 116 | Q9UL36 | |
| AALEKDCEEVGVDSV | 426 | Q6PEY2 | |
| TEEELVDGLEDCCSR | 511 | Q14679 | |
| QDAACKDAEECPETA | 826 | Q5H9R7 | |
| KDAEECPETAEAKCA | 831 | Q5H9R7 | |
| NEKEEGETADTVGCC | 491 | P11387 | |
| PCEEEAEKATCDSDF | 1146 | Q14966 | |
| CDPEEDLGKCESDNT | 376 | O94782 | |
| KCDGDEDCVDGSDEK | 51 | P98155 | |
| EESDEEVCLSSLECL | 316 | Q9UL68 |